Healthcare IT Today June 20, 2025
Brooklyn Health’s AI-Based Approach to Clinical Measurement Improves How Patient Outcomes are Measured in Central Nervous System (CNS) Clinical Trials
Brooklyn Health, a neuroscience technology company focused on objective measurement of mental health, today announced it has secured $6.5 million in seed funding. The round was led by HealthX Ventures, with participation from Metrodora Ventures, Story Ventures, RiverPark Ventures, Laconia Capital, Everywhere Ventures, Hypothesis Studio, Blue Falcon Capital, and others.
The funding comes as the company debuts its new electronic clinical outcome assessment (eCOA) solution, Willis. The comprehensive measurement solution automates legacy services through AI, easing access to critical tools necessary for successful drug development.
CNS clinical trials rely on clinical interviews as the primary outcome measure for treatment efficacy....
Today's Sponsors
Today's Sponsor